The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow

DOI: 10.1371/journal.pone.0190525

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text